Title:
CELL ACTIVATOR AND SKIN EXTERNAL COMPOSITION INCLUDING SAME
Document Type and Number:
WIPO Patent Application WO/2022/208976
Kind Code:
A1
Abstract:
The present invention addresses the problem of investigating whether serpinB2 can exhibit cell-activating activity as a result of skin external administration thereof, and providing a cell activator whereby stable quality can be ensured inexpensively. Provided is a cell activator including less than 12.5 µg/mL of sericin and 0.035 µg/mL or more of serpinB2.
Inventors:
HASEGAWA MUNECHIKA (JP)
Application Number:
PCT/JP2021/041589
Publication Date:
October 06, 2022
Filing Date:
November 11, 2021
Export Citation:
Assignee:
SETEKA CORP (JP)
International Classes:
A61K38/17; A61K8/64; A61K38/57; A61P17/00; A61P17/02; A61P43/00; A61Q19/00; A61Q19/08; C12N5/071; C12N5/074
Foreign References:
| JP2002526382A | 2002-08-20 | |||
| JP2005289889A | 2005-10-20 | |||
| JP2005218460A | 2005-08-18 | |||
| JP2014159389A | 2014-09-04 | |||
| JPH10265403A | 1998-10-06 | |||
| JP2020132539A | 2020-08-31 | |||
| JP2020132540A | 2020-08-31 | |||
| JP2001064148A | 2001-03-13 | |||
| JP2021038175A | 2021-03-11 |
Attorney, Agent or Firm:
HIRAKI & ASSOCIATES (JP)
Download PDF: